Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

The stock now trades at one of its lowest price-to-earnings ratios in years. The Danish pharmaceutical giant announced it was ...

Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...

The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

On Tuesday, Merck ( MRK -1.56%) wasn't one of the better-performing pharmaceutical stocks. In contrast to certain peers, the company's share price declined following the release of second-quarter ...

The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and ...

Shares in Danish drugmaker Novo Nordisk were down nearly 20% in pre-market trading Tuesday morning after the company cuts its sales and profit estimates.

Celcuity stock (NASDAQ: CELC), a clinical-stage biotechnology company, experienced an extraordinary 3x surge in a single ...

Investors soured on the sector when Elevance, an insurer, handed in disappointing results and shared a downbeat outlook.